EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, VTVT: Vtv Theraptcs Cl A

07 Nov 25 15:57
LAST:

26.02

CHANGE:
 0.55		OPEN:
24.31		HIGH:
27.00		ASK:
7.81		VOLUME:
9.9K
CHG(%):
2.16		PREV:
25.47		LOW:
24.31		BID:
3.05		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 2524.3127.0024.3126.0217.6K
06 Nov 2525.9425.9425.3125.475.0K
05 Nov 2522.4624.5422.4524.246.3K
04 Nov 2523.0124.9223.0124.925.2K
03 Nov 2520.2325.3020.2323.4014.2K
31 Oct 2520.0421.8920.0421.753.0K
29 Oct 2519.8421.0719.8021.076.0K
28 Oct 2521.3421.9920.2020.8911.6K
27 Oct 2520.5021.5020.5021.192.3K
24 Oct 2519.5020.9019.5020.901.8K

COMPANY PROFILE

Name:Vtv Theraptcs Cl A
About:vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases. The company's lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes; and TTP273, an orally available small molecule glucagon-like peptide 1 receptor agonists that is in Phase I clinical trial for the treatment of postprandial hyperglycemia in cystic fibrosis related diabetes patients, as well as in Phase II trial for the treatment of type 2 diabetes. It is also developing HPP737, an orally administered non- central nervous system penetrant PDE4 inhibitor that has completed Phase 1 trials for the treatment of inflammatory diseases. In addition, the company's other programs include HPP3033, a non-electrophilic therapeutic approach to activating the nuclear factor erythroid 2"related factor 2 (Nrf2) pathway for the treatment of chronic diseases associated with oxidative stress. It has a license agreement Newsoara Biopharma Co., Ltd. o develop and commercialize phosphodiesterase type 4 inhibitors program, including the compound HPP737. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Group LLC.
Sector:Healthcare
Industry:Biotechnology
Address:3980 Premier Drive, High Point, NC, United States, 27265
Website:https://vtvtherapeutics.com
CUSIP:918385105
CIK:0001641489
ISIN:US9183852048
FIGI:BBG009DT9XJ0

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:24.814.9%
MA10:22.9913.2%
MA20:22.1017.7%
MA50:21.4021.6%
MA100:18.5240.5%
MA200:18.2442.6%
STO9:83.96 
STO14:84.66 
RSI14:85.43 
MTM14:5.41
ROC14:0.26 
ATR:1.72 
Week High:27.003.8%
Week Low:20.0429.8%
Month High:27.003.8%
Month Low:19.5042.6%
Year High:27.003.8%
Year Low:12.62106.2%
Volatility:27.12 

RECENT SPLITS

Date Ratio
21 Nov 20231-40